Davis Polk advised Alpha Capital Acquisition Company on the deal. Shearman & Sterling advised Citigroup Inc. and BofA Securities, Inc. acting as initial purchasers on the...
Alpha Capital Acquisition’s $230 Million Initial Public Offering
AmerisourceBergen’s $2 Billion Facilities
Davis Polk advised the joint lead arrangers and the agent in the deal. A $1 billion term loan facility was provided to AmerisourceBergen Corporation to finance...
Evernorth’s Acquisition of MDLIVE
Davis Polk advised MDLIVE on the deal. MDLIVE, Inc. executed its acquisition by Evernorth. The transaction, which is expected to close in the second quarter of...
Figure Acquisition Corp. I’s $287.5 Million Initial Public Offering
Davis Polk advised Figure Acquisition Corp. I on the deal while Paul Hastings, LLP advised Citigroup Global Markets Inc.Figure Acquisition Corp. I executed its $287.5 million...
Kennametal’s $300 Million Notes Offering
Davis Polk advised the joint book-running managers on the offering. Kennametal Inc. executed its offering of $300 million aggregate principal amount of 2.800% senior notes due 2031. ...
Ayala Pharmaceuticals’ $25 Million Private Placement
Davis Polk advised the placement agent, Jefferies, in the deal. Ayala Pharmaceuticals, Inc. executed its $25 million private placement of common stock and warrants to purchase common...
Lucid Motors’ Business Combination with Churchill Capital Corp IV
Davis Polk advised Lucid Motors in the deal, while Weil advised Churchill Capital Corp IV.Lucid Motors executed its business combination with Churchill Capital Corp IV (CCIV),...
Fusion Acquisition Corp.’s $2.4 Billion Merger with MoneyLion
Davis Polk represented MoneyLion, while White & Case LLP represented Fusion Acquisition Corp. in the transaction. Fusion Acquisition Corp., a special purpose acquisition company (SPAC), executed...
UP Fintech’s $65 Million Convertible Notes Private Placement
Davis Polk advised UP Fintech Holding Limited on the deal. UP Fintech Holding Limited (“Tiger Brokers”), a company listed on the Nasdaq Global Select Market, executed...
Charles River Laboratories’ $875 Million Acquisition of Cognate BioServices
Davis Polk and Hannes Snellman advised Charles River Laboratories International on the deal. Weil, Gotshal & Manges advised Charles River Laboratories on the antitrust aspects of...
JPMorgan Chase & Co.’s €1.5 Billion Notes Offering
Davis Polk advised JPMorgan Chase & Co. as special U.S. counsel in the offering. JPMorgan Chase & Co. executed the offering of €1.5 billion aggregate principal amount...
Biogen’s $1.75 Billion Exchange Offer
Davis Polk advised the dealer managers in the deal. Biogen Inc. (Nasdaq: BIIB) announced the commencement of a private offer to exchange any and all of its...